Taveras Arthur
- SEC CIK
- 0001830901
No open-market purchases or sales filed in the past year.
Current role at each company
- XFOR X4 Pharmaceuticals, IncChief Scientific Officeras of Oct 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Taveras Arthur as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | Taveras ArthurChief Scientific Officer | SSale | −76.9K | $0.56 | −$43.1K | −16.5%388.0K after | |
| Mar 11, 2024 (view filing) | Mar 11 | Same day | Taveras ArthurChief Scientific Officer | SSale | −14.2K | $0.88 | −$12.5K | −5.7%234.3K after | |
| Feb 12, 2024 (view filing) | Feb 12 | Same day | Taveras ArthurChief Scientific Officer | SSale | −787 | $1.01 | −$794.87 | −0.3%248.5K after | |
| Nov 3, 2023 (view filing) | Nov 1 | 2 days | Taveras ArthurChief Scientific Officer | SSale | −67.7K | $0.73 | −$49.4K | −21.4%249.3K after | 10b5-1 |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Taveras ArthurChief Scientific Officer | SSale | −16.8K | $0.84 | −$14.1K | −16.3%86.4K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Taveras ArthurChief Scientific Officer | SSale | −928 | $0.93 | −$863.04 | −0.9%103.2K after |